journal article·2025-05-21

Nanocatalytic Antioxidation Enables Aortic Endothelial Repair and Aortic Aneurysm Treatment

Di Jiang, Bowen Yang, Jianlin Shi

Nano Letters· Volume 25· Issue 20
Publisher page

Abstract

The pathogenesis of lethal aortic aneurysm (AA) is closely associated with oxidative stress, which damages endothelial cells (ECs) and disrupts the endothelial barrier, subsequently affecting vascular smooth muscle cells (VSMCs). This work presents a nanocatalytic antioxidation strategy for AA treatment using a two-dimensional (2D) ZIF-67 nanosheet (NS) as an efficient antioxidase mimic. The material features a planar two-dimensional morphology and an antioxidative coordination environment, presenting an excellent H 2 O 2 -scavenging performance ( K m = 19.72 mM). Cell experiments reveal that ZIF-67 NS is capable of protecting ECs against oxidation, inhibiting the occurrence of the endothelial-to-mesenchymal transition (EndMT) and maintaining the integrity of the vascular endothelial barrier. The antioxidative effect of the material also protects the VSMCs. In vivo experiments further demonstrate the desirable efficacy of the nanocatalyst in suppressing the formation of AA. This nanocatalytic antioxidation strategy provides a promising therapeutic approach for AA treatment and other cardiovascular diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Infectious Aortic and Vascular Conditions · Aortic aneurysm repair treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of High Performance Ceramics and Superfine Microstructure

Shanghai Institute of Ceramics, Chinese Academy of Sciences, and Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medical Sciences (2021RU012)

Center of Materials Science and Optoelectronics Engineering

University of Chinese Academy of Sciences

Funding

National Key Research and Development Program of China · Chinese Academy of Medical Sciences · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China

References (28)

Show source-provided references
1. 10.1161/01.CIR.0000154569.08857.7A10.1161/01.CIR.0000154569.08857.7A ↗
2. 10.1038/nrcardio.2010.18710.1038/nrcardio.2010.187 ↗
3. 10.1038/s41392-023-01325-710.1038/s41392-023-01325-7 ↗
4. 10.3390/biomedicines1201000310.3390/biomedicines12010003 ↗
5. 10.3389/fimmu.2018.0198510.3389/fimmu.2018.01985 ↗
6. 10.1038/labinvest.2014.10010.1038/labinvest.2014.100 ↗
7. 10.1038/s41569-018-0023-y10.1038/s41569-018-0023-y ↗
8. 10.1126/science.aas943210.1126/science.aas9432 ↗
9. 10.1093/eurheartj/ehac77110.1093/eurheartj/ehac771 ↗
10. 10.1038/ncpcardio093710.1038/ncpcardio0937 ↗
11. 10.1056/NEJMoa171595510.1056/NEJMoa1715955 ↗
12. 10.1016/j.jacc.2009.08.08410.1016/j.jacc.2009.08.084 ↗
13. 10.1097/FJC.000000000000105410.1097/FJC.0000000000001054 ↗
14. 10.1016/S0140-6736(03)13637-910.1016/S0140-6736(03)13637-9 ↗
15. 10.1038/ncpcardio121110.1038/ncpcardio1211 ↗
16. 10.1093/eurheartj/ehq39610.1093/eurheartj/ehq396 ↗
17. 10.1089/ars.2023.052410.1089/ars.2023.0524 ↗
18. 10.3390/antiox1308092210.3390/antiox13080922 ↗
19. 10.1002/adma.20190177810.1002/adma.201901778 ↗
20. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
21. 10.5551/jat.5437910.5551/jat.54379 ↗
22. 10.1002/adma.20220445510.1002/adma.202204455 ↗
23. 10.1016/j.jacc.2018.08.218810.1016/j.jacc.2018.08.2188 ↗
24. 10.1016/j.biomaterials.2020.12040610.1016/j.biomaterials.2020.120406 ↗
25. 10.1016/j.matlet.2012.05.07710.1016/j.matlet.2012.05.077 ↗
26. 10.1126/science.115251610.1126/science.1152516 ↗
27. 10.1021/acsomega.0c0398110.1021/acsomega.0c03981 ↗
28. 10.1016/j.jhazmat.2021.12530810.1016/j.jhazmat.2021.125308 ↗